H. Ochs

No ORCID on file · 15 papers in corpus · active 1986-1995

Study types

  • article 11
  • book-chapter 4

Condition tags

  • endometriosis 9
  • dysmenorrhea 2
  • chronic_pelvic_pain 1
  • mesh:D004716 1
  • dyspareunia 1
article 1995
A randomized, comparative trial of triptorelin depot (D-Trp6-LHRH) and danazol in the treatment of endometriosis
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/0028-2243(94)02016-8
article 1994
Behandlung von Endometriose mit dem GnRH-Agonisten Buserelin (Suprecur®): Eine multizentrische Studie
Geburtshilfe und Frauenheilkunde ·doi:10.1055/s-2007-1022341

A phase III multicentre study was carried out with the GnRH agonist buserelin (Suprecur) at five university institutions (Dept. of Obstetrics and Gynaecology of Essen, Kiel, Tübingen, Münster and Erlangen) to evaluate the effect of Busereli…

article 1993
Inflammatory reaction in endometriotic tissue: an immunohistochemical study
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/0028-2243(93)90052-e
article 1993
Topographie von Endometrioseherden in Abhängigkeit vom Schweregrad der Erkrankung
·doi:10.1007/bf02266108
book-chapter 1993
Topographie von Endometrioseherden in Abhängigkeit vom Schweregrad der Erkrankung
·doi:10.1007/978-3-642-77857-5_216
article 1991
Aussagekraft der Tumormarker CA 125, CA 19-9, CA 15-3 und CEA bei Endometriose
Geburtshilfe und Frauenheilkunde ·doi:10.1055/s-2007-1026212

CA 125, CA 19-9, CA 15-3 and CEA were measured in 42 patients with histologically verified endometriosis, who had been treated for six months by the LHRH-analogue buserelin (900 mcg/d intranasally). Before therapy, for all of the markers te…

article 1990
Residualendometriose nach LHRH-Analogtherapie
Geburtshilfe und Frauenheilkunde ·doi:10.1055/s-2007-1026452

LHRH analogue therapy has proved effective in the treatment of endometriosis. Although in the majority of patients a marked reduction in AFS implant score is observed, in some cases residual endometriotic foci are macroscopically suspected …

article 1989
Abhängigkeit zwischen ovarieller Suppression und Rückgang der Endometriose-Implantate bei LHRH-Analog(Buserelin)-Therapie
·doi:10.1007/bf02417630
book-chapter 1989
Abhängigkeit zwischen ovarieller Suppression und Rückgang der Endometriose-Implantate bei LHRH-Analog(Buserelin)-Therapie
·doi:10.1007/978-3-642-74784-7_484
book-chapter 1989
Behandlung der Endometriose mit Buserelin: klinische Ergebnisse
·doi:10.1515/9783110869590-006
book-chapter 1989
Behandlung der Endometriose mit Buserelin: metabolische Effekte
·doi:10.1515/9783110869590-011
article 1989
LH-RH agonist (Buserelin): treatment of endometriosis
Archives of gynecology and obstetrics ·doi:10.1007/bf00934075
article 1987
Metabolische Effekte und allgemeine Nebenwirkungen bei Endometriose-behandlung mit einem LHRH-Agonisten
Geburtshilfe und Frauenheilkunde ·doi:10.1055/s-2008-1035798

Between 1983 and 1986 40 patients were treated for external genital endometriosis with the LHRH agonist buserelin. Ovarian suppression was achieved for a period of six months with a dose of 900 to 1,800 mcg per day. In addition to gynecolog…

article 1986
Effect of LH-RH agonist therapy in the treatment of endometriosis (German experience).
Progress in clinical and biological research
article 1986
Management of endometriosis.
Progress in clinical and biological research